ARCHIVES

FDA Approves Arranon For Leukemia And Lymphoma

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | December 30, 2005

Download PDF Visit The Full Archive

Related Articles

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

ODAC Chairman: Time Was Tight For Meeting

November 10, 1995

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

Cancer Researchers Share 2001 Nobel Prize For Cell Cycle, Chromosome Discoveries.

October 12, 2001